This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ettlin, R. A. Articles by Prentice, D. E. Search for Related Content PubMed PubMed Citation Articles by Ettlin, R. A. Articles by Prentice, D. E. Social Bookmarking                         What's this?

Causes of Death in Rodent Toxicity and Carcinogenicity Studies

Sandoz Pharma Ltd., CH-4002 Basel, Switzerland

Peter Stirnimann

Sandoz Pharma Ltd., CH-4002 Basel, Switzerland

David E. Prentice

Prentice Consultancy Services Ltd., GB-Godmanchester, Cambs PE18 8JD, United Kingdom

Peto test procedures for the statistical evaluation of carcinogenicity studies require that each tumor in an animal that died intercurrently (or was sacrificed in extremis) be classified as either fatal, probably fatal, incidental, or probably incidental. There is considerable controversy as to whether or not the cause of death can be established with accuracy in rodent studies. In the present article, the causes of death or ill-being as found in 10 consecutive carcinogenicity studies—5 studies with 2400 OFA (Sprague-Dawley-derived) and Wistar rats and 5 studies with 2400 OF1 and NMRI mice—were re-examined. A cause of death or moribund state had been established in more than 80% of the cases in rats and in more than 70% in mice. These causes were, in rats, mainly pituitary tumors, chronic progressive nephropathy (males), mammary gland tumors (females), and subcutaneous tumors (males); in mice, mainly hemolymphoreticular tumors, lung tumors, liver tumors (males), and glomerulonephropathy. The criteria used for determining the tumorous or non-tumorous lesions as the cause of death were based on in-life and pathological findings. The validity of such procedures, the possibility of improving criteria in the future, and the usefulness of establishing causes of death in safety assessment are discussed.

Key Words: Liver tumors • lung tumors • tumors of the hemolymphoreticular system • mammary gland tumors • pituitary tumors • skin tumors • skin ulcerations • chronic progressive nephropathy • polyarteritis

Toxicologic Pathology, Vol. 22, No. 2, 165-178 (1994)
DOI: 10.1177/019262339402200210


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				W.-C. Son and C. Gopinath Early Occurrence of Spontaneous Tumors in CD-1 Mice and Sprague--Dawley Rats Toxicol Pathol, June 1, 2004; 32(4): 371 - 374. [Abstract] [PDF]

				G. Long Recommendations to Guide Determining Cause of Death in Toxicity Studies Toxicol Pathol, February 1, 2004; 32(2): 269 - 270. [PDF]

				J. K. Haseman, E. Ney, A. Nyska, and G. N. Rao Effect of Diet and Animal Care/Housing Protocols on Body Weight, Survival, Tumor Incidences, and Nephropathy Severity of F344 Rats in Chronic Studies Toxicol Pathol, October 1, 2003; 31(6): 674 - 681. [Abstract] [PDF]

				W. Sontag, R. Wirth, A. Luz, E. Schaffer, and V. Volf Dosimetry and pathology of 237Np in female rats Human and Experimental Toxicology, February 1, 1997; 16(2): 89 - 100. [Abstract] [PDF]

				R. L. Kodell, B.-N. Blackwell, T. J. Bucci, and D. L. Greenman Cause-of-Death Assignment at the National Center for Toxicological Research Toxicol Pathol, May 1, 1995; 23(3): 241 - 247. [Abstract] [PDF]